• NeuroBANK Banking On Collaboration, Compassion, Clinical Research

    Jun 12, 2018, 08:10 AM by Michael Croft

    Bio-IT World | A Harvard professor and Bio-IT World 2018 Best Practices Award winner is banking on old-fashioned collaboration and compassion, along with 21st century technology, to help principal investigators collect data for clinical research and to facilitate the development of new therapies and cures.

    Full story
  • Glytec Adds Smart Meter to Growing Network of Connected Solution Partner

    Jun 11, 2018, 13:33 PM by Michael Croft
    WALTHAM, MA, UNITED STATES - Jun 5, 2018 - For millions of patients with diabetes who’ve been unable to achieve their treatment goals, few programs have the potential to reduce A1C faster or more effectively than Glytec’s virtual insulin titration service
    Full story
  • All The Gear But Still No Idea? Why Machines Alone Can’t Cure Cancer

    Jun 11, 2018, 09:50 AM by Michael Croft

    Bio-IT World Contributed Commentary | Despite the hype and fanfare that has accompanied massive supercomputers and AI platforms in recent years, there is still no tool capable of delivering answers to questions such as, “How do I cure a particular patient’s type of cancer?”

    Full story
  • #BioIT18 News, Notes, And Coverage

    Jun 8, 2018, 10:50 AM by Michael Croft

    Bio-IT World | Last month in Boston, over 3,500 members of the biotech and life science industries came together to share thoughts, insights, and technologies during the 2018 Bio-IT World Conference & Expo. The conference featured 16 tracks including Bioinformatics, FAIR Data for Genomic Applications, Data Transfer, Clinical Genomics, Next-Gen Sequencing Informatics, and more.

    Full story
  • Reporters’ Notebook: Clustal, FAIR Data, Rare Diseases, Data Science Community At #BioIT18

    Jun 8, 2018, 10:35 AM by Michael Croft

    Bio-IT World | When over 3,500 members of the biotech and life science industries spend three days together, there’s more good stuff than a writer can possibly fit into post-event coverage. Our Reporters’ Notebook comprises some of the bits and pieces that we collected over the three days in Boston.

    Full story
  • Bill And Melinda Gates Start A Nonprofit Biotech In Boston

    Jun 7, 2018, 11:51 AM by Michael Croft
    Forbes | The Bill & Melinda Gates Medical Research Institute, which is holding an event today to show off its plans, will aim to develop new medicines and vaccines for malaria, tuberculosis, and diarrhea, which together account for 2.6 million deaths a year globally, many of them in children.
    Full story
  • Wasdell Group invests £500k in new microbiological and analytical lab

    Jun 7, 2018, 11:37 AM by Michael Croft
    NEWCASTLE, UK - Jun 7, 2018 - The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, is investing £500k in a new laboratory at its Newcastle site
    Full story
  • CRF Health Industry Luminaries to Share eSource Expertise in Clinical Trials at DIA 2018

    Jun 7, 2018, 10:23 AM by Michael Croft
    PLYMOUTH MEETING, PA - Jun 7, 2018 - Plymouth Meeting, PA – June 07, 2018: CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced that it will host a series of interactive workshops and speaker sessions at DIA’s 2018 Global Annual Meeting, June 24-28, Boston, MA
    Full story
  • Data Are Forever

    Jun 7, 2018, 08:15 AM by Michael Croft

    Bio-IT World | For attendees at this year's Bio-IT World Conference & Expo, perhaps the biggest focal point was the near-permanence of data—particularly juxtaposed against the limited contemporaneous uses for any given dataset in healthcare and life-science IT.

    Full story
  • BioIVT to Host Webinar Describing In Vitro Models to Predict Herb-Drug Interactions

    Jun 6, 2018, 15:15 PM by Michael Croft
    WESTBURY, NY - Jun 6, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be hosting a webinar entitled “Whole-cell In Vitro Models Can Predict Clinically-relevant Herb-Drug Interactions (HDIs)” at 11 am ET on June 20
    Full story
  • Wellcome Sanger Institute Sequences Reference Genomes Of 3,000 Dangerous Bacteria

    Jun 6, 2018, 10:30 AM by Michael Croft

    Bio-IT World Brief | The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences.

    Full story
  • Finding The Usable In FAIR Data At #BioIT18

    Jun 6, 2018, 08:20 AM by Michael Croft

    Bio-IT World | Last year at the Bio-IT World Conference & Expo, three teams competed in a Hackathon to see if they could make their datasets more Findable, Accessible, Interoperable, and Reusable (FAIR). This year, the organizers of the FAIR Hackathon wanted to see if they could take those principles to the next level.

    Full story
  • Open Cell launches shipping container labs at Shepherd's Bush Market to accelerate biotech start-up businesses

    Jun 6, 2018, 07:23 AM by Michael Croft
    LONDON, UK - Jun 6, 2018 - Open Cell has joined forces with regeneration specialist, U+I, and the London Borough of Hammersmith and Fulham and SynbiCITE to launch a biolab to offer affordable spaces at the Old Laundry Yard in Shepherd’s Bush Market
    Full story
  • MyHeritage DNA Suffers Security Breach, Only Email Addresses Compromised

    Jun 5, 2018, 16:25 PM by Michael Croft
    Bio-IT World News Brief  MyHeritage, an Israeli online genealogy platform company, announced yesterday evening that the email addresses and hashed passwords of 92 million MyHeritage users were found on a private server not linked to the company. The security breach includes users who signed up for the service on or before October 26, 2017.
    Full story
  • Buying GitHub Would Take Microsoft Back To Its Roots

    Jun 4, 2018, 10:32 AM by Michael Croft
    Bloomberg.com | For Microsoft, acquiring GitHub would be both a return to the company's earliest roots and a sharp turnaround from where it was a decade ago.
    Full story
  • Carl Zimmer Hosts “Ask Me Anything” Session On Reddit, Tackles Heredity, Genetics, DTC Testing

    Jun 1, 2018, 10:15 AM by Michael Croft

    Bio-IT World | To celebrate the recent publication of his book She Has Her Mother’s Laugh, New York Times science columnist Carl Zimmer hosted an “Ask Me Anything” (AMA) session yesterday on Reddit, covering a wide range of topics from consumer genetic testing and how genomic information should be integrated into healthcare, to heredity and where Zimmer stands on genetic cloning.

    Full story
  • Who Gets Credit For CRISPR? Prestigious Award Singles Out Three

    May 31, 2018, 09:26 AM by Michael Croft
    STAT | Emmanuelle Charpentier, Jennifer Doudna, and Virginijus Šikšnys will each receive a gold medal and share the $1 million that comes with the Kavli Prize in nanoscience. This is only the latest verdict on the controversial question of who deserves credit for the revolutionary genome-editing tool, CRISPR.
    Full story
  • BioIVT Granted Human Tissue Authority License for a Second UK Site

    May 31, 2018, 08:28 AM by Michael Croft
    WESTBURY, NY - May 31, 2018 - BioIVT, a leading provider of biospecimens and related services, today announced that the Human Tissue Authority (HTA) has granted a satellite license to its West Sussex facility
    Full story
  • Plugging Your Skill Sets Into Big Data

    May 30, 2018, 08:05 AM by Michael Croft

    Bio-IT World | When 3,500 members of the biotech and life sciences industries converged in Boston for the Bio-IT World Conference & Expo, the idea of hiring the right people in Big Data popped up again and again. A panel of CEOs and executives converged to discuss this very topic.

    Full story
  • Certara Scientists to Present Model-informed Drug Development, Systems Pharmacology and MBMA Advances at PAGE 2018

    May 29, 2018, 12:46 PM by Michael Croft
    PRINCETON, NJ - May 29, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, health economic outcomes research, market access and real-world evidence services, today announced its participation in 28 sessions at the Population Approach Group in Europe (PAGE) 2018 Annual Meeting
    Full story